Collaboration between patient advocacy and industry to create a master protocol to investigate the novel therapy acetyl-L-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 gangliosides and ataxia-telangiectasia

Collaboration between patient advocacy and industry to create a master protocol to investigate the novel therapy acetyl-L-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 gangliosides and ataxia-telangiectasia

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular genetics and metabolism 2023-02, Vol.138 (2), p.107099, Article 107099
Hauptverfasser: Fields, Taylor, Crowe, Joslyn, Evans, Will, Greenfield, Julie, Hopkin, Justin, Thornton, Jennifer K., Lewi, Daniel, Mathieson, Toni, Pangonis, Diana
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:
ISSN:1096-7192
1096-7206
DOI:10.1016/j.ymgme.2022.107099